Kari Hemminki
11 – 20 of 528
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Haplotype analysis identifies functional elements in monoclonal gammopathy of unknown significance
- Contribution to journal › Article
-
Mark
Burden of malignant mesothelioma in China during 1990-2019 and the projections through 2029
- Contribution to journal › Article
- 2023
-
Mark
Population-Attributable Fractions of Personal Comorbidities for Liver, Gallbladder, and Bile Duct Cancers
- Contribution to journal › Article
-
Mark
Re: Mark N. Brook, Holly Ní Raghallaigh, Koveela Govindasami, et al. Family History of Prostate Cancer and Survival Outcomes in the UK Genetic Prostate Cancer Study. Eur Urol 2023;83:257-66
- Contribution to journal › Letter
-
Mark
Are population level familial risks and germline genetics meeting each other?
- Contribution to journal › Scientific review
-
Mark
Autoimmune diseases as comorbidities for liver, gallbladder, and biliary duct cancers in Sweden
- Contribution to journal › Article
-
Mark
Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression?
- Contribution to journal › Article
-
Mark
Personal comorbidities and their subsequent risks for liver, gallbladder and bile duct cancers
- Contribution to journal › Article
- 2022
-
Mark
Familial Risks for Liver, Gallbladder and Bile Duct Cancers and for Their Risk Factors in Sweden, a Low-Incidence Country
- Contribution to journal › Article
-
Mark
Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia : a CRuCIAL study
- Contribution to journal › Letter
